Patents Assigned to A-BIOPHARMA
  • Anti-viral and hepatic-targeted drugs
    Patent number: 12539332
    Abstract: Disclosed herein are identified compound fragments, compounds and their pharmaceutically acceptable salts, isotopes or solvates, useful as antiviral drug and/or as a hepatic-targeted drug, such as for the treatment of HBV, HDV and/or HIV. Formula (I).
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: February 3, 2026
    Assignee: A-BIOPHARMA
    Inventors: Cyril B. Dousson, David Dukhan